Patent · US Active

Inhibition of cancer growth and metastasis

US9895414B2 · kind B2 · utility

3Cited by
0References
2Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 20, 2013
Grant dateFeb 20, 2018
Priority date
Expiry dateDec 20, 2033

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2500/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to methods for treating or preventing cancer and metastasis. More particularly, the present invention relates to methods for treating or preventing cancer by decreasing the expression and/or activity of Flightless I. Also provided are methods for inhibiting the growth of a cancerous cell and methods for inhibiting formation and/or growth of a tumor which also rely on decreasing the expression and/or activity of Flightless I. The present invention also extends to methods for diagnosing cancer, methods for determining if a subject is susceptible to developing cancer, and methods for assessing progression of cancer based on the finding that increased expression and/or activity of Flightless I is associated with cancer development, growth and metastasis. The present invention also provides methods for screening for a candidate therapeutic agent useful for treating or preventing cancer, and related pharmaceutical compositions and kits.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.